The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

    Covid-19: Govt amends CSR norms; likely to help boost funding for vaccines, drugs

    Copy URL
    Embed

    The government has amended the corporate social responsibility rules under the companies law that is likely to help boost funding for developing new vaccines, drugs and medical devices related to the coronavirus pandemic. With the latest amendments, companies engaged in research and development (R&D) activity of new vaccine, drugs and medical devices in their normal course of business have been allowed to undertake R&D activity of new vaccine, drugs and medical devices related to COVID-19 under the CSR ambit.

    595views
    Have something to say? Post your comment
    The Economic Times